At Nords Weight Loss Clinic, we offer medically-supervised weight-loss injections designed to help you break through plateaus and achieve lasting change. Our approach combines advanced injectable therapies with personalised nutritional and lifestyle support to help you reach up to 20% of excess body-weight reduction with safe, premium care.
They mimic the body's natural GLP-1 hormone to reduce appetite, slow stomach emptying and promote fullness.
Ideal for clients who've tried diets and exercise but need more structured medical support.
Administered only under professional supervision — ensuring safety, correct dosing, and monitoring.
Combined with our holistic programme of nutrition, behavioural coaching and follow-up for longer-term sustainability.
Natural hormone regulation for effective appetite control.
Feel fuller for longer periods after meals.
Brain signals help reduce appetite naturally.
Better blood sugar control and reduced cravings.
Long-term results with lifestyle changes.
Professional guidance throughout your journey.
What are Weight Loss Injections?
Weight loss injections generally work by mimicking a natural hormone in the body called GLP-1 (glucagon-like peptide-1). This hormone helps regulate appetite, slows stomach emptying so you feel fuller for longer, and signals the brain to reduce hunger, making it easier to eat less. Some injections also improve how the body handles insulin, which stabilizes blood sugar and reduces cravings. Combined with lifestyle changes like healthier eating and increased activity, these injections can lead to significant and sustainable weight loss over time.
At Nords Weight Loss Clinic, we offer FDA-approved weight loss medications tailored to your individual health needs. Our specialists provide comprehensive medical oversight to ensure safe and effective treatment.
Ozempic is a prescription medication used for type 2 diabetes and certain heart health risks. It mimics GLP-1, helping regulate appetite, blood sugar, digestion, and fullness. At Nords, our specialists personalize your dosage, monitor progress, and provide nutritional guidance for safe, sustainable weight management.
Zepbound is a prescription medication approved for overweight and obesity. It mimics GLP-1 and GIP, helping regulate appetite, improve fullness, and support effective weight loss. At Nords, our specialists tailor your treatment, monitor progress, and provide nutritional guidance for safe, sustainable weight management.
Mounjaro is a prescription medication used for type 2 diabetes and obesity. It mimics GLP-1 and GIP, helping control blood sugar, appetite, and overall metabolic health. At Nords, our specialists personalize your dosage, monitor progress, and provide nutritional guidance for safe, sustainable weight management.
A full medical consultation and health assessment to design your injection plan.
Weekly injectable treatments administered or guided by our medical team.
Ongoing follow-up appointments with our nutritionists and lifestyle coaches for habit formation.
Access to our premium clinic environment, located in Nairobi, for the best comfort and privacy.
Weight loss injections are once-a-week injectable medication administered subcutaneously (under the skin), typically in the thigh, abdomen, or upper arm.
At Nords, our medical team will guide you through your first injection and provide support for self-administration at home if you qualify.
All injections are supervised by trained professionals to ensure safety and correct dosing.
Nords Weight Loss Clinic would like to walk with you on your weight loss journey. Talk to us today...
Talk to our expert medical team at Nords Polyclinic Nairobi
Evidence-based answers to the questions we hear most about weight loss injections.
In the current clinical landscape, the strongest injectable medications for weight loss are those in the GLP-1 (glucagon-like peptide-1) / GIP (glucose-dependent insulinotropic polypeptide) receptor agonist class.
For example, Semaglutide (brand names like Wegovy when used for weight loss) and Tirzepatide (brand name Zepbound for weight-loss indication) currently offer the greatest efficacy. Semaglutide is well supported by trials for weight management; tirzepatide appears to deliver even greater weight loss in comparative studies.
In short: if "best" means the greatest average weight-loss potential (with appropriate monitoring and lifestyle support), then tirzepatide (dual-agonist) currently leads, followed closely by semaglutide (single GLP-1 agonist). But "best" also depends on patient suitability, cost, access, side-effect profile, and local regulatory approval.
First, important context: Ozempic (semaglutide) is approved for type 2 diabetes rather than for primary weight-loss indication (though it does cause weight loss).
In studies of semaglutide used for weight loss (sometimes under other brand names/doses), the typical weight-loss figures help set expectations: one cohort lost a mean of ~6.7 kg at 3 months (≈5.9% of body weight) and ~12.3 kg at 6 months (~10.9%) in patients with obesity/overweight.
Breaking that down to "per month" gives about 2–4 kg in the early months for many (depending on baseline body-weight, dose, diet, exercise). Some sources say about 1-3 pounds (~0.5-1.5 kg) a week (thus 2-6 kg a month) in favourable circumstances.
Yes, but with important caveats. They can be safe and effective when used under medical supervision, but they are not without risk, require appropriate patient selection, monitoring, and integration with lifestyle changes.
There is no single answer; duration depends on the drug, the indication (diabetes vs obesity), response, tolerance, cost, and long-term management plan.
For semaglutide (and by extension off-label use like Ozempic for weight loss):
This is a critically important topic to convey clearly: stopping weight-loss injections often leads to relapse or regain of body weight, especially if lifestyle changes have not become deeply established and support is not maintained.
Here are key contraindications, cautions and patient types to discuss:
Contraindications (i.e., should generally not take unless under very special supervision):
Precautions / when to discuss carefully with provider:
In your counselling for your bariatric-care context, advise: "We will undertake a full assessment (thyroid history, endocrine history, renal/ pancreatic function, pregnancy plans) before considering Ozempic."
